ResearcherUniversity of TorontoNo recent work listed

Andrew E. Shouksmith

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5050572463. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2019: 1 paper

Papers 1

Identification and Characterization of AES-135, a Hydroxamic Acid-Based HDAC Inhibitor That Prolongs Survival in an Orthotopic Mouse Model of Pancreatic Cancer. Co-author DOI 10.1021/acs.jmedchem.8b01957 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Melissa L. Fishel · 1 shared paper, 2019 · strength 0.07
- Paper Identification and Characterization of AES-135, a Hydroxamic Acid-Based HDAC Inhibitor That Prolongs Survival in an Ort… DOI 10.1021/acs.jmedchem.8b01957 ↗
Fenil Shah · 1 shared paper, 2019 · strength 0.07
- Paper Identification and Characterization of AES-135, a Hydroxamic Acid-Based HDAC Inhibitor That Prolongs Survival in an Ort… DOI 10.1021/acs.jmedchem.8b01957 ↗
Patrick Thomas Gunning · 1 shared paper, 2019 · strength 0.07
- Paper Identification and Characterization of AES-135, a Hydroxamic Acid-Based HDAC Inhibitor That Prolongs Survival in an Ort… DOI 10.1021/acs.jmedchem.8b01957 ↗
Stephen F Konieczny · 1 shared paper, 2019 · strength 0.07
- Paper Identification and Characterization of AES-135, a Hydroxamic Acid-Based HDAC Inhibitor That Prolongs Survival in an Ort… DOI 10.1021/acs.jmedchem.8b01957 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.